THREE International Announces GLP THREE™ Listing in Prescriber’s Digital Reference (PDR)

Addition brings total to seven THREE products included in the widely used clinical reference for healthcare professionals. 

LEHI, Utah — THREE International announced that GLP THREE™, its metabolic health dietary supplement, is now listed in the Prescriber’s Digital Reference, a widely used clinical resource that provides healthcare professionals with standardized information on product ingredients, safety data, and formulation details.

With the addition of GLP THREE, a total of seven THREE International wellness products, and two personal care products are now included in the PDR database, reflecting the company’s continued focus on transparency, third-party verification, and science-supported product development.

Unlike promotional directories, the Prescriber’s Digital Reference functions as a clinical information platform used by physicians, pharmacists, and other healthcare professionals to review independently presented product composition, safety guidance, and usage information.

Metabolic Health Formulation

According to the PDR listing, GLP THREE contains 320 mg of GLP THREE Complex, built around the company’s proprietary Metabolic Boost Complex-267 (MBC-267™). The formulation includes bioactive peptides derived from salmon protein hydrolysate, mushroom glycolipids, and botanical ingredients such as Panax ginseng extract, saffron extract, and humulus lupulus extract.

Research referenced in the listing indicates that the natural molecules in GLP THREE can support health of the GLP-1 metabolic pathway on the body.

The product is delivered using the company’s proprietary cellular absorption technology, designed to support efficient nutrient uptake.

“Having GLP THREE included in the Prescriber’s Digital Reference is an important milestone and strong validation of the science behind our formulations. We are committed to ensuring that healthcare professionals can review our ingredients, safety data, and formulation approach in a standardized, credible setting.”

— Dr. Dan Gubler, Chief Scientific Officer, THREE International

Quality, Transparency, and Verification

THREE International states that its products undergo third-party laboratory testing to verify potency, purity, label accuracy, and safety. Independent laboratories screen for heavy metals, contaminants, and ingredient authenticity to help ensure that product contents align with labeled specifications.

Company leadership notes that the expanding number of products listed in the Prescriber’s Digital Reference reflects an ongoing commitment to quality control, ingredient transparency, and scientific accountability within the nutritional supplement category.

Healthcare professionals can access additional details on GLP THREE directly through the Prescriber’s Digital Reference database.

* Statements related to GLP THREE have not been evaluated by the U.S. Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

About THREE International

THREE International develops nutritional supplements designed to support metabolic health, weight management, and overall wellbeing. The company emphasizes ingredient transparency, third-party testing, and science-based product development, and distributes its products globally through a network of independent distributors and customers.